Skip to main content
Search

Portfolio planning and risk management in the pharmaceutical industry 1

Part 1 of 2
Published on March 29, 2017   53 min

A selection of talks on Pharmaceutical Sciences

Please wait while the transcript is being prepared...
0:00
I am Joachim Greuel, Managing Director at Bioscience Valuation, a company engaged in portfolio management and risk management as well. And I'm going to talk about Portfolio Planning and Risk Management in the Pharmaceutical Industry.
0:21
Before I begin, a few words about myself, I studied biology in Germany and in the UK, and received a PhD in neuroscience from the Max-Planck-Institute for Brain Research. I also hold an MBA from the Wharton School of the University of Pennsylvania in the US with a healthcare management and finance focus. I also served as academic director and professor at the IE Business School in Madrid, teaching courses related to pharmacoeconomics and also related to portfolio managements in the pharmaceutical industry. Before I co-founded Bioscience Valuation more than 18 years ago, I worked for Bayer Pharmaceuticals as head of a research group for couple of years and also as investment manager for a venture capital fund in Switzerland.
1:21
The presentation is divided into four parts. I will start with a short introduction and then move on to the evaluation of individual projects. The evaluation of individual projects is a prerequisite for portfolio management. The third part will talk about portfolio planning and risk management, and the final section will focus on project and portfolio value maximization.
Show
Hide

Portfolio planning and risk management in the pharmaceutical industry 1

Embed in course/own notes